Champions of Cell and Gene Therapy – The Medicine Maker
How do we ensure that not only the rich benefit from cell and gene therapy? Rob Collison of Cambridge Consultants says: It’s about more than cutting costs
How do we ensure that not only the rich benefit from cell and gene therapy? Rob Collison of Cambridge Consultants says: It’s about more than cutting costs
This whitepaper describes the benefits of introducing advanced wireless capabilities into surgical and critical care settings, the technical approaches to achieve this, and the challenges that can arise. It concludes with our vision for some exemplar use cases.
The future promises a digitally connected healthcare system that empowers both patients and carers alike. So, what’s the next step for pharma companies and device developers with ambitions in the space?
The current state of in vitro diagnostics is no longer fit for purpose. Inadequate procedures mean that critical insights are often missed, while expenditure statistics on both sides of the Atlantic reveal lagging levels of investment.
この度のケンブリッジコンサルタンツのブランドリニューアルにより、The Engineとの関係がより強固になりました。The Engineは、MIT(マサチューセッツ工科大学)によって設立されたベンチャーキャピタルであり、気候変動、健康といった長期での社会的課題解決を目指すアーリーステージの「タフテック」企業を支援しています。戦略的パートナーとして、士気が高く、使命感に溢れているスタートアップの起業家と関わることは、弊社にとって大きな喜びです。